Rapid7 Acquires Leading Web Application Security Provider, tCell
October 15 2018 - 4:30PM
Rapid7, Inc. (NASDAQ: RPD), powering SecOps through its visibility,
analytics and automation cloud, today announced it acquired
tCell.io, Inc., a leading provider of web application threat
defense and monitoring. Through this acquisition, Rapid7 plans to
expand its application security capabilities and help its customers
better assess, monitor, and protect against application-based
attacks.
tCell’s runtime application self-protection (RASP) and web
application monitoring is expected to extend the capabilities of
Rapid7’s Insight Platform by enhancing web application security at
every level—from browser to server—helping organizations identify
and block attacks. tCell was recognized as a strong performer in
The Forrester New Wave™: Runtime Application Self-Protection, Q1
2018.
Rapid7's Insight Platform delivers a unique combination of
network visibility, security analytics, and orchestrated automation
used by organizations to manage risk, detect and stop attacks, and
orchestrate security operations across their modern networks. In
addition to web application security, Rapid7’s Insight capabilities
include complete vulnerability management, security information and
event management (SIEM), user behavior analytics (UBA), and
security orchestration and automation (SOAR).
“Today’s fragmented ecosystem continues to be a challenge for
security teams as they battle escalating threats while still
supporting rapid innovation,” said Lee Weiner, chief product
officer at Rapid7. “In order to address these issues, a practical
and holistic view of application security is vital. tCell shares
our vision for application security and we are thrilled to welcome
them to the Rapid7 team.”
“Attacks on web applications are exploding as companies push out
more applications faster and faster,” said Michael Feiertag, chief
executive officer at tCell. “It was clear from the start of our
conversations with Rapid7 that they understand this challenge and
are committed to addressing it. We are incredibly excited to join
the team and work together to deliver businesses the best possible
application security solutions.”
The acquisition of tCell is not expected to have a material
financial impact to Rapid7’s Annualized Recurring Revenue growth,
revenue, and non-GAAP earnings (loss) per share for calendar year
2018, as guided on August 6, 2018. About Rapid7
Rapid7 (NASDAQ:RPD) powers the practice of SecOps by delivering
shared visibility, analytics, and automation that unites security,
IT, and DevOps teams. The Rapid7 Insight platform empowers these
teams to jointly manage and reduce risk, detect and contain
attackers, and analyze and optimize operations. Rapid7 technology,
services, and research drive vulnerability management, application
security, incident detection and response, and log management for
more than 7,200 organizations across more than 120 countries,
including 54% of the Fortune 100.
About tCelltCell is a next-gen cloud WAF that
enables web applications, APIs and microservices to defend
themselves against attacks. With unparalleled visibility into
application behavior, tCell’s technology dramatically reduces false
positives, protects applications from attacks, and delivers
actionable data to prevent future attacks. tCell’s adaptive
deployment models enable Security and DevOps organizations to
deploy industry-leading security alongside mission-critical
applications. tCell’s customers include companies like Veeva
Systems, Zenefits, and John Muir Health. More information can be
found at tcell.io.
Cautionary Language Concerning Forward-Looking
Statements
This press release includes forward-looking statements. All
statements contained in this press release other than statements of
historical facts, including, without limitation, statements
regarding the expected benefits of the acquisition of tCell and the
solutions that Rapid7 will develop with the tCell technology,
including expansion of its application security capabilities and
the Rapid7 Insight Platform, and the expected benefits of such
solutions and Rapid7’s expectation regarding the impact of the
tCell transaction on Rapid7’s Annualized Recurring Revenue growth,
revenue, and non-GAAP earnings (loss) per share for calendar year
2018 are forward-looking statements. The words “anticipate,”
“believe,” “continue,” “estimate,” “expect,” “intend,” “may,”
“will” and similar expressions are intended to identify
forward-looking statements. We have based these forward-looking
statements largely on our current expectations and projections
about future events and financial trends that we believe may affect
our financial condition, results of operations, business strategy,
short-term and long-term business operations and objectives and
financial needs. These forward-looking statements are subject to a
number of risks and uncertainties, including, without limitation,
our ability to innovate and offer products and professional
services that address the dynamic threat landscape, our ability to
innovate and manage our growth, our ability to integrate acquired
operations, as well as other risks and uncertainties set forth in
the “Risk Factors” section of our Quarterly Report on Form 10-Q
filed with the Securities and Exchange Commission for the period
ended June 30, 2018 filed with the Securities and Exchange
Commission on August 7, 2018, and subsequent reports that we file
with the Securities and Exchange Commission. Moreover, we operate
in a very competitive and rapidly changing environment. New risks
emerge from time to time. It is not possible for our management to
predict all risks, nor can we assess the impact of all factors on
our business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those
contained in any forward-looking statements we may make. In light
of these risks, uncertainties and assumptions, we cannot guarantee
future results, levels of activity, performance, achievements or
events and circumstances reflected in the forward-looking
statements will occur. We are under no duty to update any of these
forward-looking statements after the date of this press release to
conform these statements to actual results or revised expectations,
except as required by law. You should, therefore, not rely on these
forward-looking statements as representing our views as of any date
subsequent to the date of this press release.
Press contact:Caitlin DohertyRapid7, Communications Program
Leadpress@rapid7.com (857) 990-4240
Investors:Jeff Bray, CFARapid7, Vice President, Investor
Relationsinvestors@rapid7.com(857) 990-4074
Rapid7 (NASDAQ:RPD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rapid7 (NASDAQ:RPD)
Historical Stock Chart
From Apr 2023 to Apr 2024